Description

Yeztugo® (Lenacapavir Injection)

Yeztugo® (lenacapavir injection) is a long-acting prescription medication developed for HIV prevention in eligible adults and adolescents. Administered as a subcutaneous injection every six months after the recommended initiation regimen, Yeztugo offers a convenient, long-duration dosing schedule that may improve treatment adherence for individuals seeking an alternative to daily oral medication.

Lenacapavir belongs to a novel class of antiviral medications known as HIV-1 capsid inhibitors. It works by interfering with multiple stages of the HIV life cycle, helping reduce the risk of HIV acquisition when used as prescribed.

Key Features

Long-acting injectable formulation
Administered once every six months after initiation
Innovative HIV-1 capsid inhibitor
Prescription medication for eligible patients
May improve adherence by reducing dosing frequency
Intended for use under the supervision of a qualified healthcare provider

Product Information

Generic Name: Lenacapavir Injection
Brand Name: Yeztugo®
Dosage Form: Subcutaneous Injection
Therapeutic Class: HIV-1 Capsid Inhibitor
Administration: Healthcare professional administration as prescribed

At Pure Axis Distribution, we are committed to supplying authentic pharmaceutical products sourced from trusted manufacturers. We provide reliable distribution services, competitive pricing, and responsive customer support to healthcare providers, clinics, pharmacies, and authorized purchasers.